The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 23, 2019

Filed:

Nov. 21, 2016
Applicant:

Sunnybrook Health Sciences Centre, Toronto, CA;

Inventors:

Juan Carlos Zuniga-Pflucker, Toronto, CA;

Geneve Awong, North York, CA;

Ross La Motte-Mohs, Germantown, MD (US);

Assignee:

Sunnybrook Health Sciences Centre, Toronto, Ontario, CA;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/12 (2015.01); A61K 35/17 (2015.01); C12N 5/077 (2010.01); C12N 5/0789 (2010.01); C12N 5/0783 (2010.01); G01N 33/50 (2006.01); C12N 5/0775 (2010.01);
U.S. Cl.
CPC ...
C12N 5/0647 (2013.01); A61K 35/17 (2013.01); C12N 5/0636 (2013.01); C12N 5/0646 (2013.01); G01N 33/5005 (2013.01); A61K 2035/124 (2013.01); C12N 5/0663 (2013.01); C12N 5/0669 (2013.01); C12N 2501/2302 (2013.01); C12N 2501/2307 (2013.01); C12N 2501/2315 (2013.01); C12N 2501/42 (2013.01); C12N 2502/13 (2013.01); C12N 2502/1305 (2013.01); C12N 2502/137 (2013.01); C12N 2502/1311 (2013.01); C12N 2502/1317 (2013.01); C12N 2502/1323 (2013.01); C12N 2502/1329 (2013.01); C12N 2502/1335 (2013.01); C12N 2502/1341 (2013.01); C12N 2502/1347 (2013.01); C12N 2502/1352 (2013.01); C12N 2502/1358 (2013.01); C12N 2502/1364 (2013.01); C12N 2502/1376 (2013.01); C12N 2502/1382 (2013.01); C12N 2502/1388 (2013.01); C12N 2502/1394 (2013.01); C12N 2502/99 (2013.01); C12N 2506/02 (2013.01); C12N 2506/11 (2013.01); C12N 2506/45 (2013.01);
Abstract

Human progenitor T cells that are able to successfully engraft a murine thymus and differentiate into mature human T and NK cells are described. The human progenitor T cells have the phenotype CD34+CD7+CD 1a−CD5− or CD34+CD7+CD1a−CD5+ and are derived from human hematopoietic stem cells, embryonic stem cells and induced pluripotent stem cells by coculture with cells expressing a Notch receptor ligand (OP9-DL1 or OP9-DL4). Such cells are useful in a variety of applications including immune reconstitution, the treatment of immunodeficiencies and as carriers for genes used in gene therapy.


Find Patent Forward Citations

Loading…